Prediction: This AI Chip Stock Will Be the Biggest Winner of 2027 (Hint: It’s Not Nvidia, AMD, or Broadcom)

TSMC is reportedly set to raise chipmaking fees by 10% in 2027, while Nvidia and AMD are passing through higher costs with chip price increases of more than 15% and about 10%-15%, respectively. The article argues that TSMC's 73% pure-play foundry market share, AI-driven volume growth, and pricing power could drive 2027 EPS above the $21.93 consensus estimate, potentially reaching $23.70 versus $16.93 expected in 2026. At 21x forward earnings, the stock is presented as inexpensive relative to Nvidia and AMD, with a hypothetical 30x multiple implying a $711 2027 price target, or 56% upside.

Analysis

The investable issue is not a generic foundry-price increase but whether TSM can preserve incremental pricing after accounting for overseas-fab dilution, accelerated depreciation, and customer-specific concessions. If leading-edge wafer pricing rises while utilization remains tight, TSM’s gross-margin leverage should exceed that of fabless customers because its fixed-cost base converts revenue upside directly into earnings; the critical read-through is likely upward 2027 margin guidance rather than the announced list-price change. NVDA’s product scarcity and software lock-in make it the most able to pass through costs, while AMD has less room to absorb higher wafer and advanced-packaging costs without sacrificing share or gross margin.

Near term, the article is unlikely to be a fresh catalyst: reported pricing actions are already broadly embedded in AI supply-chain expectations. Over the next 1-3 months, monitor TSM monthly revenue, CoWoS/advanced-packaging capacity commentary, and any changes in 2nm customer commitments; these can validate whether price realization is improving versus merely offsetting higher capex and overseas operating costs. Over 6-18 months, the larger risk is that hyperscaler custom silicon—benefiting AVGO most—diversifies demand away from merchant GPUs, reducing the urgency of NVDA/AMD wafer demand even if total AI compute spending remains elevated.

Consensus appears too focused on TSM as a cheaper AI proxy and too little on its role as the industry’s capacity bottleneck. That supports a relative long, but a simple valuation rerating thesis is fragile: geopolitical risk, Taiwan-dollar appreciation, and a faster ramp of non-Taiwan capacity can cap the multiple regardless of earnings beats. The thesis is falsified by sustained leading-edge utilization below roughly 90%, gross-margin guidance failing to expand despite revenue growth, or evidence that price increases are offset by customer rebates and packaging-cost inflation.

Key Decisions for Investors

• Initiate a 6-12 month long TSM / short AMD pair, sized beta-neutral. TSM captures wafer-price and utilization upside; AMD faces greater pass-through and competitive elasticity. Reassess if AMD’s data-center GPU gross margin expands or TSM’s next annual gross-margin outlook misses consensus.
• Maintain NVDA as the preferred fabless exposure versus AMD, but avoid adding solely on this pricing narrative. NVDA can pass through input costs more readily; use any 8-10% AI-semicap pullback to add, with a stop based on a material reduction in Blackwell/rack-scale supply outlook rather than wafer-price headlines.
• Watch AVGO for a second-order beneficiary rather than chase TSM immediately: firm custom-ASIC order commentary from hyperscalers would indicate AI demand is broadening beyond GPUs and can sustain TSM utilization. Add AVGO only if backlog conversion and semiconductor operating-margin guidance remain intact.
• Set an event alert around TSM’s next quarterly gross-margin and capex guide. A revenue beat without margin expansion is a warning that overseas fabs, depreciation, or customer concessions are consuming the apparent pricing benefit; reduce the TSM-over-AMD spread in that outcome.